These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21684821)

  • 1. Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance.
    Stroffolini T; Trevisani F; Pinzello G; Brunello F; Tommasini MA; Iavarone M; Di Marco V; Farinati F; Del Poggio P; Borzio F; Borzio M; Caturelli E; Di Nolfo MA; Frigerio M; Brancaccio G; Gaeta GB
    Dig Liver Dis; 2011 Nov; 43(11):875-80. PubMed ID: 21684821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of hepatocellular carcinoma in Italy.
    Stroffolini T; Andreone P; Andriulli A; Ascione A; Craxi A; Chiaramonte M; Galante D; Manghisi OG; Mazzanti R; Medaglia C; Pilleri G; Rapaccini GL; Simonetti RG; Taliani G; Tosti ME; Villa E; Gasbarrini G
    J Hepatol; 1998 Dec; 29(6):944-52. PubMed ID: 9875641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
    Fasani P; Sangiovanni A; De Fazio C; Borzio M; Bruno S; Ronchi G; Del Ninno E; Colombo M
    Hepatology; 1999 Jun; 29(6):1704-7. PubMed ID: 10347111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
    Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
    Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.
    Van Roey G; Fevery J; Van Steenbergen W
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):61-6. PubMed ID: 10656212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
    Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.
    Cazzagon N; Trevisani F; Maddalo G; Giacomin A; Vanin V; Pozzan C; Poggio PD; Rapaccini G; Nolfo AM; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Foschi FG; Cabibbo G; Felder M; Ciccarese F; Missale G; Baroni GS; Morisco F; Pecorelli A; Farinati F;
    Liver Int; 2013 Oct; 33(9):1420-7. PubMed ID: 23758775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
    Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
    J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
    Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
    Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.
    Del Poggio P; Olmi S; Ciccarese F; Di Marco M; Rapaccini GL; Benvegnù L; Borzio F; Farinati F; Zoli M; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F;
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1927-33.e2. PubMed ID: 24582947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study.
    De Bac C; Stroffolini T; Gaeta GB; Taliani G; Giusti G
    Hepatology; 1994 Nov; 20(5):1225-30. PubMed ID: 7523273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
    Mok TS; Yeo W; Yu S; Lai P; Chan HL; Chan AT; Lau JW; Wong H; Leung N; Hui EP; Sung J; Koh J; Mo F; Zee B; Johnson PJ
    J Clin Oncol; 2005 Nov; 23(31):8041-7. PubMed ID: 16258102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects.
    Zaman S; Khan M; Alam K; Williams R
    J Trop Med Hyg; 1995 Feb; 98(1):64-8. PubMed ID: 7861482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.